Principes de réanimation dynamique

  • F. Garnier
  • C. Martin
Part of the Le point sur⋯ book series (POINT)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Choi PTL, Yip G, Quinonez LG et al. (1999) Crystalloids vs. colloids in fluid resuscitation: A systemic review. Crit Care Med 27: 200–2PubMedGoogle Scholar
  2. 2.
    Schierhout G, Roberts I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomised trials. BMJ 316: 961–4PubMedGoogle Scholar
  3. 3.
    Rackow EC, Falk JL, Fein IA et al. (1983) Fluid resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch, and saline soluntions in patients with hypovolemic and septic shock. Crit Care Med 11: 839–50PubMedGoogle Scholar
  4. 4.
    Boulain T, Achard JM, Teboul JL et al. (2002) Changes in BP induced by passive leg raising predict response to fluid loading in critically ill patients. Chest 121(4): 1245–52CrossRefPubMedGoogle Scholar
  5. 5.
    LeDoux D, Astiz ME, Carpati CM et al. (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28: 2729–32Google Scholar
  6. 6.
    Gregory JS, Bonfiglio MF, Dasta JF et al. (1991) Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 19: 1395–400PubMedGoogle Scholar
  7. 7.
    Task Force for Hemodynamic Support of Sepsis in Adult Patients (1999) Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 27: 639–60Google Scholar
  8. 8.
    Martin C, Papazian L, Perrin G et al. (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 103: 1826–31PubMedGoogle Scholar
  9. 9.
    Van den Berghe G, de Zegher F (1996) Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 24: 1580–90PubMedGoogle Scholar
  10. 10.
    Meadows D, Edwards JD, Wilkins RG et al. (1988) Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 16: 663–6PubMedGoogle Scholar
  11. 11.
    Desjars P, Pinaud M, Bugnon D et al. (1989) Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 17: 426–9PubMedGoogle Scholar
  12. 12.
    Rendl-Wenzl EM, Armbruster C, Edelmann G et al. (1993) The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 19: 151–4Google Scholar
  13. 13.
    Clements FM, de Bruijn NP (1988) Noninvasive cardiac monitoring. Crit Care Clin 4: 435–54PubMedGoogle Scholar
  14. 14.
    Altura BM (1975) Dose-response relationships for arginine vasopressin and synthetic analogs on three types of rat blood vessels: Possible evidence for regional differences in vasopressin receptor sites within a mammal. J Pharmacol Exp Ther 193: 413–23PubMedGoogle Scholar
  15. 15.
    Holmes CL, Patel BM, Russell JA et al. (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120: 989–1002CrossRefPubMedGoogle Scholar
  16. 16.
    Sharshar T, Carlier R, Blanchard A et al. (2002) Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 30: 497–500PubMedGoogle Scholar
  17. 17.
    Reid IA (1997) Rise of vasopressin deficiency in the vasodilation of septic shock. Circulation 95: 1108–10PubMedGoogle Scholar
  18. 18.
    Morales MD, Madigan J, Cullinane S et al. (1999) Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 100: 226–9PubMedGoogle Scholar
  19. 19.
    Malay MB, Ashton RC, Landry DW et al. (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47: 699–705PubMedGoogle Scholar
  20. 20.
    Grover R, Lopez A, Larente J et al. (1999) Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide-synthase inhibitor 546C88: Effect on survival in patients with septic shock. Abstr. Crit Care Med 27(Suppl.): A33Google Scholar
  21. 21.
    Poole-Wilson PA, Langer GA (1975) Effect of pH on ionic exchange and function in rat and rabbit myocardium. Am J Physiol 2,29: 570–81Google Scholar
  22. 22.
    von Planta I, Weil MH, von Planta M et al. (1991) Hypercarbic acidosis reduces cardiac resuscitability. Crit Care Med 19: 1177–82Google Scholar
  23. 23.
    Forsythe SM, Schmidt GA (2000) Sodium bicarbonate for the treatment of lactic acidosis. Chest 117: 260–7CrossRefPubMedGoogle Scholar
  24. 24.
    Cooper DJ, Walley KR, Wiggs BR et al. (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: A prospective, controlled clinically study. Ann Intern Med 112: 492–8PubMedGoogle Scholar
  25. 25.
    Mathieu D, Neviere R, Billard V et al. (1991) Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: A prospective, controlled clinical study. Crit Care Med 19: 1352–6PubMedGoogle Scholar
  26. 26.
    Rhee KH, Toro LO, McDonald GG et al. (1993) Carbicarb, sodium bicarbonate, and sodium chloride in hypoxic lactic acidosis: Effect on arterial blood gases, lactate concentrations, hemodynamic variables, and myocardial intracellular pH. Chest 104: 913–8PubMedGoogle Scholar
  27. 27.
    Stacpoole PW, Wright EC, Baumgartner TG et al. (1992) A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med 327: 1564–9PubMedGoogle Scholar
  28. 28.
    Archie JP (1981) Mathematic coupling of data. Ann Surg 193: 296PubMedGoogle Scholar
  29. 29.
    Boyd O, Grounds RM, Bennett ED (1993) A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 270: 2699–707CrossRefPubMedGoogle Scholar
  30. 30.
    Tuchschmidt J, Fried J, Astiz M et al. (1992) Elevation output and oxygen delivery improves outcome in septic shock. Chest 102: 216–20PubMedGoogle Scholar
  31. 31.
    Levy B, Bollaert PE, Charpentier C et al. (1997) Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variabiles in septic shock: A prospective, randomized, study. Intensive Care Med 23: 282–7CrossRefPubMedGoogle Scholar
  32. 32.
    Gammaitoni C, Nasraway SA (1993) Normal lactate/pyruvate ratio during overwhelming polymicrobial bacteremia and multiple organ failure. Anesthesiology 80: 213–6Google Scholar
  33. 33.
    Gattinoni L, Brazzi L, Pelosi P et al. (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333: 1025–32CrossRefPubMedGoogle Scholar
  34. 34.
    Hayes MA, Timmins AC, Yau EHS et al. (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330: 1717–22CrossRefPubMedGoogle Scholar
  35. 35.
    Rivers E, Nguyen B, Havstad S et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–77CrossRefPubMedGoogle Scholar
  36. 36.
    Hebert PC, Wells G, Blajchman MA et al. (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340: 409–17CrossRefPubMedGoogle Scholar
  37. 37.
    Wagner HM, Bennett IL, Lasagna L et al. (1956) The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bull Johns Hopkins Hosp 98: 197–215PubMedGoogle Scholar
  38. 38.
    Schumer W (1976) Steroids in the treatment of clinical septic shock. Ann Surg 333-41Google Scholar
  39. 39.
    Bone RC, Fisher CJ, Clemmer TP et al. (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317: 653–8PubMedGoogle Scholar
  40. 40.
    Sprung CL, Caralis PV, Marcial EH et al. (1984) The effects of high-dose corticosteroids in patients with septic shock. N Engl J Med 311: 1137–43PubMedGoogle Scholar
  41. 41.
    Bollaert PE, Charpentier C, Levy B et al. (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26: 645–50PubMedGoogle Scholar
  42. 42.
    Briegel J, Forst H, Haller M et al. (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 27: 723–32PubMedGoogle Scholar
  43. 43.
    Annane D, Sebille V, Troche G et al. (2000) A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283: 1038–45CrossRefPubMedGoogle Scholar
  44. 44.
    Annane D, Sebille V, Charpentier C et al. (2002) Effect of treatment with low dose of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862–71CrossRefPubMedGoogle Scholar
  45. 45.
    Marik PE, Zaloga GP (2002) Adrenal insufficiency in the critically ill: A new look at an old problem. Chest 122: 1784–96PubMedGoogle Scholar

Copyright information

© Springer-Verlag France 2005

Authors and Affiliations

  • F. Garnier
  • C. Martin

There are no affiliations available

Personalised recommendations